View Archive »
About The Cover
The cover for issue 75 of Oncotarget features Figure 7, "Antitumor efficacy of anetumab ravtansine in combination with bevacizumab in human ovarian cancer xenograft models in mice," by Quanz, et al.
|
|
Table of Contents
Editorial
|
| Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction |
|
https://doi.org/10.18632/oncotarget.26133
|
| 34031-34032 |
Research Perspectives
|
| In tumor cells thyroid hormone analogues nonimmunologically regulate PDL1 and PD1 accumulation that is antiapoptotic |
|
https://doi.org/10.18632/oncotarget.26143
|
| 34033-34037 |
Research Papers
|
| The antiangiogenic action of cisplatin on endothelial cells is mediated through the release of tissue inhibitor of matrix metalloproteinases1 from lung cancer cells |
|
https://doi.org/10.18632/oncotarget.25954
|
| 34038-34055 |
|
| Survival outcomes of CD34+CD38−LSCs and their expression of CD123 in adult AML patients |
|
https://doi.org/10.18632/oncotarget.26118
|
| 34056-34065 |
|
| Enhanced expression of PDL1 in nonmuscleinvasive bladder cancer after treatment with Bacillus CalmetteGuerin |
|
https://doi.org/10.18632/oncotarget.26122
|
| 34066-34078 |
|
| Genetic and epigenetic analyses guided by high resolution wholegenome SNP array reveals a possible role of CHEK2 in Wilms tumour susceptibility |
|
https://doi.org/10.18632/oncotarget.26123
|
| 34079-34089 |
|
| Complex formation between plateletderived growth factor receptor β and transforming growth factor β receptor regulates the differentiation of mesenchymal stem cells into cancerassociated fibroblasts |
|
https://doi.org/10.18632/oncotarget.26124
|
| 34090-34102 |
|
| Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelinexpressing human ovarian cancer models |
|
https://doi.org/10.18632/oncotarget.26135
|
| 34103-34121 |
|
| Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy via genomewide transcriptome changes |
|
https://doi.org/10.18632/oncotarget.26137
|
| 34122-34131 |
|
| Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity |
|
https://doi.org/10.18632/oncotarget.26139
|
| 34132-34141 |
|
| Phospholipidation of nuclear proteins by the human papillomavirus E6 oncoprotein: implication in carcinogenesis |
|
https://doi.org/10.18632/oncotarget.26140
|
| 34142-34158 |
|
| Two mechanisms of cardiac stem cellmediated cardiomyogenesis in the adult mammalian heart include formation of colonies and cellincell structures |
|
https://doi.org/10.18632/oncotarget.26148
|
| 34159-34175 |
|
| Aberrant Oglycosylation modulates aggressiveness in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.26169
|
| 34176-34188 |
Corrections
|
| Correction: Mobilization studies in mice deficient in sphingosine kinase 2 support a crucial role of the plasma level of sphingosine1phosphate in the egress of hematopoietic stem progenitor cells |
|
https://doi.org/10.18632/oncotarget.26195
|
| 34189-34189 |
|
| Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase1 activation |
|
https://doi.org/10.18632/oncotarget.26197
|
| 34190-34190 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
